Cannabigerovarin (CBGV) is a #0excludeGlossary minor cannabinoid naturally present in cannabis. As a varin derivative of Cannabigerol (CBG), CBGV features a shortened #1excludeGlossary alkyl side chain, distinguishing it chemically and potentially biologically. Known as a precursor molecule, CBGV contributes to the biosynthesis of other cannabinoids like THCV and CBDV. While research on CBGV remains limited, initial findings suggest it may possess therapeutic properties, including anti-inflammatory, antimicrobial, and neuroprotective effects, positioning it as a valuable component in #3excludeGlossary cannabis products.
This article needs more reliable medical references for verification or relies too heavily on primary sources. (March 2022) |
Cannabigerovarin (CBGV), the propyl homolog of cannabigerol (CBG), is a cannabinoid present in Cannabis. There is no observation related to the psychoactive or psychotropic effects of CBGV when consumed or inhaled.
![]() | |
![]() | |
Names | |
---|---|
IUPAC name 2-[(2E)-3,7-dimethylocta-2,6-dienyl]-5-propylbenzene-1,3-diol | |
Other names Cannabigerovarol CBGV | |
Identifiers | |
3D model (JSmol) | |
ChemSpider | |
PubChem CID | |
UNII | |
CompTox Dashboard (EPA) | |
| |
| |
Properties | |
C19H28O2 | |
Molar mass | 288.431 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). |